| P2093 | author name string | Duncan F Rogers | |
| P2860 | cites work | Understanding airway wall remodeling in asthma: a basis for improvements in therapy? | Q34453206 |
| | Remodeling in asthma and chronic obstructive lung disease | Q34457552 |
| | The role of inflammation and anti-inflammatory medication in asthma | Q34540636 |
| | Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force | Q34718973 |
| | Airway goblet cells: responsive and adaptable front-line defenders | Q40652298 |
| | The pathology of asthma, with special reference to changes in the bronchial mucosa | Q41286069 |
| | Hyaluronan serves a novel role in airway mucosal host defense | Q43771269 |
| | Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression | Q46727427 |
| | Physiology and pathology of tracheobronchial glands | Q33824654 |
| | Asthma. From bronchoconstriction to airways inflammation and remodeling | Q33915771 |
| | Trophic slime, allergic slime | Q33933041 |
| | The pathophysiology of asthma | Q34111957 |
| | Animal models of bronchial asthma | Q34158276 |
| | Anti-remodelling drugs for the treatment of asthma: requirement for animal models of airway wall remodelling. | Q34319663 |
| | The role of epidermal growth factor in mucus production | Q34442275 |
| | Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia | Q34442431 |
| P433 | issue | 8 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 1124-1127 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory? | |
| P478 | volume | 32 | |